These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8698283)

  • 41. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
    García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
    PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.
    Ludwig H; Adam Z; Hajek R; Greil R; Tóthová E; Keil F; Autzinger EM; Thaler J; Gisslinger H; Lang A; Egyed M; Womastek I; Zojer N
    J Clin Oncol; 2010 Oct; 28(30):4635-41. PubMed ID: 20823423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood monoclonal B-cells predict the event free survival in multiple myeloma.
    Mitterer M; Lanthaler AJ; Schnabel B; Svaldi M; Oduncu F; Coser P; Emmerich B; Huemer H; Straka C
    Leuk Lymphoma; 2001 Apr; 41(3-4):387-95. PubMed ID: 11378552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple myeloma without detectable Ig synthesis.
    Ferraris AM; Haupt E; Ratti M
    Acta Haematol; 1979; 62(5-6):257-61. PubMed ID: 121666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multiple myelomas. I. Generalities].
    Hoerni B; Hoerni-Simon G
    Bord Med; 1972 Jun; 5(11):1249-54. PubMed ID: 5054777
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multiple myeloma of bones. Retrospective study of prognostic factors based on a series of 243 patients].
    Bataille R; Donadio D; Morlock G; Rosenberg F; Blotman F; Sany J; Simon L; Izarn P; Serre H
    Rev Rhum Mal Osteoartic; 1979 Feb; 46(2):77-83. PubMed ID: 432517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light chain myeloma: A brief report from India.
    Singh N; Agrawal N; Sekhri R; Mehta A; Kumar D; Vishwakarma G; Ahmed R; Bhurani D
    Indian J Pathol Microbiol; 2019; 62(3):441-444. PubMed ID: 31361235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
    Graziani MS; Lippi U
    Clin Chem; 1986 Dec; 32(12):2220-1. PubMed ID: 3096615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors in multiple myeloma.
    Alexanian R; Balcerzak S; Bonnet JD; Gehan EA; Haut A; Hewlett JS; Monto RW
    Cancer; 1975 Oct; 36(4):1192-201. PubMed ID: 1175123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation.
    Desikan KR; Dhodapkar MV; Hough A; Waldron T; Jagannath S; Siegel D; Barlogie B; Tricot G
    Leuk Lymphoma; 1997 Oct; 27(3-4):315-9. PubMed ID: 9402328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
    Bladé J; Lust JA; Kyle RA
    J Clin Oncol; 1994 Nov; 12(11):2398-404. PubMed ID: 7964956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new case of IgE multiple myeloma with review of literature.
    Vignon G; Cognée AS; Carrere F; Masson I; Borde F; Augereau PF; Aucher P; Lellouche F
    Ann Biol Clin (Paris); 2017 Aug; 75(4):442-444. PubMed ID: 28751289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunochemical evaluation of monoclonal gammopathies: heavy chain to light chain ratio is of little practical value for detecting IgD myelomas and free light chains.
    Bianchi P; MacNamara E; Bergami MR; Gasparro C; Jones R; Whicher JT; Bienvenu J; Aguzzi F
    Clin Chem; 1992 Feb; 38(2):317-9. PubMed ID: 1541025
    [No Abstract]   [Full Text] [Related]  

  • 57. An unusual case of Bence Jones myeloma with extremely low levels of monoclonal immunoglobulin.
    Ozaki M; Yamanaka H
    Oral Surg Oral Med Oral Pathol; 1986 May; 61(5):498-503. PubMed ID: 3086787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biclonal gammopathy in multiple myeloma: a case report.
    Bakta IM; Sutarka IN
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal and biclonal immunoglobulin-producing disorders.
    Osterborg A; Mellstedt H
    Eur J Haematol Suppl; 1989; 51():11-8. PubMed ID: 2697582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.